Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Lenalidomide × Clear all

NCT01032291 2013-05-21

A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer

Phase 2 Terminated

51 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms